These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 17256303)

  • 1. Clinical, radiographic and histological analysis of the effects of mineral trioxide aggregate used in direct pulp capping and pulpotomies of primary teeth.
    Caicedo R; Abbott PV; Alongi DJ; Alarcon MY
    Aust Dent J; 2006 Dec; 51(4):297-305. PubMed ID: 17256303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of mineral trioxide aggregate and formocresol as pulp-capping agents in pulpotomized primary teeth.
    Agamy HA; Bakry NS; Mounir MM; Avery DR
    Pediatr Dent; 2004; 26(4):302-9. PubMed ID: 15344622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodentine used as a pulp-capping agent in primary pig teeth.
    Shayegan A; Jurysta C; Atash R; Petein M; Abbeele AV
    Pediatr Dent; 2012; 34(7):e202-8. PubMed ID: 23265156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of mineral trioxide aggregate, calcium hydroxide and formocresol for pulpotomies in primary teeth.
    Moretti AB; Sakai VT; Oliveira TM; Fornetti AP; Santos CF; Machado MA; Abdo RC
    Int Endod J; 2008 Jul; 41(7):547-55. PubMed ID: 18479381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of formocresol and mineral trioxide aggregate as pulpotomy agents in deciduous teeth.
    Srinivasan D; Jayanthi M
    Indian J Dent Res; 2011; 22(3):385-90. PubMed ID: 22048576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dentin bridge formation after mineral trioxide aggregate (MTA) pulpotomies in primary teeth.
    Maroto M; Barbería E; Planells P; García Godoy F
    Am J Dent; 2005 Jun; 18(3):151-4. PubMed ID: 16158803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mineral trioxide aggregate as pulp capping agent for primary teeth pulpotomy: 2 year follow up study.
    Subramaniam P; Konde S; Mathew S; Sugnani S
    J Clin Pediatr Dent; 2009; 33(4):311-4. PubMed ID: 19725237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of mineral trioxide aggregate and formocresol as pulp medicaments for pulpotomies in primary molars.
    Noorollahian H
    Br Dent J; 2008 Jun; 204(11):E20. PubMed ID: 18425074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and radiographic evaluation of pulpotomies employing calcium hydroxide and trioxide mineral aggregate.
    Percinoto C; de Castro AM; Pinto LM
    Gen Dent; 2006; 54(4):258-61. PubMed ID: 16903198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and histological responses of human dental pulp to MTA and combined MTA/treated dentin matrix in partial pulpotomy.
    Mehrvarzfar P; Abbott PV; Mashhadiabbas F; Vatanpour M; Tour Savadkouhi S
    Aust Endod J; 2018 Apr; 44(1):46-53. PubMed ID: 28833942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of a novel alternative to conventional formocresol-zinc oxide eugenol pulpotomy for the treatment of pulpally involved human primary teeth: diode laser-mineral trioxide aggregate pulpotomy.
    Saltzman B; Sigal M; Clokie C; Rukavina J; Titley K; Kulkarni GV
    Int J Paediatr Dent; 2005 Nov; 15(6):437-47. PubMed ID: 16238654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human pulpal response to mineral trioxide aggregate (MTA): a histologic study.
    Chacko V; Kurikose S
    J Clin Pediatr Dent; 2006; 30(3):203-9. PubMed ID: 16683667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulp treatment for extensive decay in primary teeth.
    Smaïl-Faugeron V; Courson F; Durieux P; Muller-Bolla M; Glenny AM; Fron Chabouis H
    Cochrane Database Syst Rev; 2014 Aug; (8):CD003220. PubMed ID: 25099759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mineral trioxide aggregate pulpotomies: a case series outcomes assessment.
    Witherspoon DE; Small JC; Harris GZ
    J Am Dent Assoc; 2006 May; 137(5):610-8. PubMed ID: 16739540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of pulpal responses to pulpotomy and pulp capping with biodentine and mineral trioxide aggregate in dogs.
    De Rossi A; Silva LA; Gatón-Hernández P; Sousa-Neto MD; Nelson-Filho P; Silva RA; de Queiroz AM
    J Endod; 2014 Sep; 40(9):1362-9. PubMed ID: 25146016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and radiographic outcomes of pulpotomized primary molars treated with white or gray mineral trioxide aggregate and ferric sulfate--long-term follow-up.
    Frenkel G; Kaufman A; Ashkenazi M
    J Clin Pediatr Dent; 2012; 37(2):137-41. PubMed ID: 23534318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of bioactive glass, mineral trioxide aggregate, ferric sulfate, and formocresol as pulpotomy agents in rat molar.
    Salako N; Joseph B; Ritwik P; Salonen J; John P; Junaid TA
    Dent Traumatol; 2003 Dec; 19(6):314-20. PubMed ID: 15022999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scanning electron microscopy evaluation of the hard tissue barrier after pulp capping with calcium hydroxide, mineral trioxide aggregate (MTA) or ProRoot MTA.
    Reston EG; de Souza Costa CA
    Aust Endod J; 2009 Aug; 35(2):78-84. PubMed ID: 19703080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulpotomy of human primary molars with MTA and Portland cement: a randomised controlled trial.
    Sakai VT; Moretti AB; Oliveira TM; Fornetti AP; Santos CF; Machado MA; Abdo RC
    Br Dent J; 2009 Aug; 207(3):E5; discussion 128-9. PubMed ID: 19629145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mineral trioxide aggregate vs. formocresol in pulpotomized primary molars: a preliminary report.
    Eidelman E; Holan G; Fuks AB
    Pediatr Dent; 2001; 23(1):15-8. PubMed ID: 11242724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.